180 related articles for article (PubMed ID: 14150757)
1. THE BASIS FOR IMMUNITY TO MOUSE TYPHOID. 2. ANTIBODY FORMATION DURING THE CARRIER STATE.
TURNER KJ; JENKIN CR; ROWLEY D
Aust J Exp Biol Med Sci; 1964 Apr; 42():229-36. PubMed ID: 14150757
[No Abstract] [Full Text] [Related]
2. THE BASIS FOR IMMUNITY TO MOUSE TYPHOID. 3. CELL-BOUND ANTIBODY.
ROWLEY D; TURNER KJ; JENKIN CR
Aust J Exp Biol Med Sci; 1964 Apr; 42():237-48. PubMed ID: 14150758
[No Abstract] [Full Text] [Related]
3. THE BASIS FOR IMMUNITY TO MOUSE TYPHOID. I. THE CARRIER STATE.
JENKIN CR; ROWLEY D; AUZINS I
Aust J Exp Biol Med Sci; 1964 Apr; 42():215-28. PubMed ID: 14150756
[No Abstract] [Full Text] [Related]
4. BASIS FOR IMMUNITY TO TYPHOID IN MICE AND THE QUESTION OF "CELLULAR IMMUNITY".
JENKIN CR; ROWLEY D
Bacteriol Rev; 1963 Dec; 27(4):391-404. PubMed ID: 14097348
[No Abstract] [Full Text] [Related]
5. DETECTION OF TYPHOID CARRIERS.
BOKKENHEUSER V
Am J Public Health Nations Health; 1964 Mar; 54(3):477-86. PubMed ID: 14128664
[No Abstract] [Full Text] [Related]
6. Problems of anti-typhoid immunity and protective vaccination against typhoid.
Karolcek J
Lek Pr; 1969; 7(1):3-153. PubMed ID: 4917329
[No Abstract] [Full Text] [Related]
7. [ON STUDIES ON TYPHOID BACILLI CARRIERS. II].
MUENNICH D; LAKATOS M
Z Gesamte Inn Med; 1963 Aug; 18():694-701. PubMed ID: 14085699
[No Abstract] [Full Text] [Related]
8. The behaviour of a mutant strain of Salmonella typhimurium in experimental mouse typhoid.
HOBSON D
J Hyg (Lond); 1957 Sep; 55(3):322-33. PubMed ID: 13475777
[No Abstract] [Full Text] [Related]
9. Antigenic determinants of Salmonella for production of "clearance" factor in mouse typhoid.
Nakano M; Saito K; Toyasaki N
Jpn J Microbiol; 1970 Mar; 14(2):163-70. PubMed ID: 4910537
[No Abstract] [Full Text] [Related]
10. [CHANGES IN ANTIBACTERIAL IMMUNITY TO TYPHOID UNDER THE INFLUENCE OF DYSENTERY INFECTION AND INFLUENZA].
PINEGIN BV
Zh Mikrobiol Epidemiol Immunobiol; 1963 Aug; 40():29-34. PubMed ID: 14091794
[No Abstract] [Full Text] [Related]
11. New findings in the immunobiological study of typhoid carriers and of anti-typhoid immunity.
KAROLCEK J; DRASKOVICOVA M; ODLER I
J Hyg Epidemiol Microbiol Immunol; 1962; 6():436-41. PubMed ID: 13962571
[No Abstract] [Full Text] [Related]
12. [Treatment of patients with typhoid and paratyphoid fever by use of typhoid-paratyphoid B vaccines with the aim of prevention of carrier state formation].
Bilibin AF; Kornilova II; Antonova IV; Kilesso VA; Riadneva OE; Taratorina OM; Izmaĭlova NB; Khazanova LE
Klin Med (Mosk); 1965 Aug; 43(8):112-7. PubMed ID: 4957973
[No Abstract] [Full Text] [Related]
13. [IMMUNOBIOLOGIC MODIFICATIONS IN CONVALESCENT TYPHOID FEVER PATIENTS SUBJECTED TO ANTI-TYPHOID VACCINATION ANDT TREATED WITH 4-HYDROXY-19-NORTESTOSTERONE-17-CYCLOPENTYL PROPIONATE].
LOSCHIAVO F; BUCCHIARONE A
Riforma Med; 1964 Oct; 78():1133-5. PubMed ID: 14236442
[No Abstract] [Full Text] [Related]
14. Prevention of development of carriers in typhoid and paratyphoid fever.
Kilesso VA; Bilibin AF; Tendetnik YY; Kornilova II; Antonova IV; Musabayev IK; Nevsky MV; Kusminova ML; Vasilyeva AV
J Hyg Epidemiol Microbiol Immunol; 1973; 17(1):95-103. PubMed ID: 4196796
[No Abstract] [Full Text] [Related]
15. USE OF DIFFUSION CHAMBER IN STUDIES OF IMMUNITY OF EXPERIMENTAL TYPHOID.
AKIYAMA T; MAEDA K; USHIBA D
J Bacteriol; 1964 Apr; 87(4):975-6. PubMed ID: 14139529
[No Abstract] [Full Text] [Related]
16. Suggested adoption of a non-motile variant of strain Ty 2 for vaccination against typhoid fever.
Anderson ES
Prog Immunobiol Stand; 1971; 5():373-7. PubMed ID: 4573944
[No Abstract] [Full Text] [Related]
17. Early antibody response in mice to either infection or immunization with Salmonella typhimurium.
Kenny K; Herzberg M
J Bacteriol; 1967 Mar; 93(3):773-8. PubMed ID: 5337833
[TBL] [Abstract][Full Text] [Related]
18. Studies on the nature of immunity in experimental typhoid. Application of chrome vaccine in mouse typhoid. IV. Cellular factors in susceptibility and resistance.
ANDO K; TAKEI S
Jpn J Exp Med; 1954 Aug; 24(4):247-55. PubMed ID: 13242256
[No Abstract] [Full Text] [Related]
19. [VIRULENCE OF LEVOMYCETIN-RESISTANT TYPHO-PARATYPHOID BACTERIA ISOLATED FROM TYPHOID PATIENTS AND CARRIERS FOLLOWING LEVOMYCETIN THERAPY].
GNETNEV AM
Antibiotiki; 1964 Aug; 9():750-3. PubMed ID: 14239569
[No Abstract] [Full Text] [Related]
20. [EVALUATION OF VACCINES AND OF THE EFFECTIVENESS OF VACCINATIONS AGAINST TYPHOID FEVER. XI. EVALUATION OF THE IMMUNOGENIC CAPACITY OF K, N, P, S, T VACCINES BY AN ACTIVE TEST ON MICE INFECTED WITH S. TYPHI WITH ZYMOSAN].
KOSTRZEWSKI J; PLACHCINSKA J
Przegl Epidemiol; 1963; 17():71-80. PubMed ID: 14053747
[No Abstract] [Full Text] [Related]
[Next] [New Search]
